Question · Q4 2025
Hannah Rudoff of Piper Sandler asked about Weave's long-term pricing strategy for its expanding AI capabilities, including the AI Receptionist and Unified Inbox, to effectively capture the value delivered to customers. Hannah Rudoff also inquired about the stabilization of churn rates and average sales prices (ASPs) in Weave's newer verticals, specifically asking if these metrics have begun to stabilize for older specialty medical cohorts.
Answer
CEO Brett White confirmed that Weave will monetize these capabilities, with the exact pricing model (additional module vs. bundle inclusion) still being determined. He emphasized that the ability to attach to the labor budget by proving labor savings and revenue generation provides confidence in monetizing the AI omnichannel receptionist functionality, noting Weave licenses by location and consumption, not per seat. Regarding churn and ASPs, CFO Jason Christiansen confirmed that churn decreased through the second half of 2025, with Q4 returning to 2023/2024 rates, and noted nice improvement in specialty medical in Q4 due to increased integrations. CEO Brett White added that improvements happen over quarters, not years, as integrations deepen, leading to lower churn and customer acquisition costs (CAC) over time, a pattern observed across all verticals Weave enters.
Ask follow-up questions
Fintool can predict
WEAV's earnings beat/miss a week before the call